Advertisement

Index by author

March 01, 1996; Volume 24,Issue 3

A

  1. Ansari, G A

    1. Interactions of melphalan with glutathione and the role of glutathione S-transferase.
      S Awasthi, K K Bajpai, J T Piper, S S Singhal, A Ballatore, W E Seifert, Y C Awasthi and G A Ansari
      Drug Metabolism and Disposition March 1996, 24 (3) 371-374;

  2. Appanna, G

    1. A sensitive method for determination of cytochrome P4502D6 activity in vitro using bupranolol as substrate.
      G Appanna, B K Tang, R Mller and W Kalow
      Drug Metabolism and Disposition March 1996, 24 (3) 303-306;

  3. Augustijns, P F

    1. CYP3A-like cytochrome P450-mediated metabolism and polarized efflux of cyclosporin A in Caco-2 cells.
      L S Gan, M A Moseley, B Khosla, P F Augustijns, T P Bradshaw, R W Hendren and D R Thakker
      Drug Metabolism and Disposition March 1996, 24 (3) 344-349;

  4. Awasthi, S

    1. Interactions of melphalan with glutathione and the role of glutathione S-transferase.
      S Awasthi, K K Bajpai, J T Piper, S S Singhal, A Ballatore, W E Seifert, Y C Awasthi and G A Ansari
      Drug Metabolism and Disposition March 1996, 24 (3) 371-374;

  5. Awasthi, Y C

    1. Interactions of melphalan with glutathione and the role of glutathione S-transferase.
      S Awasthi, K K Bajpai, J T Piper, S S Singhal, A Ballatore, W E Seifert, Y C Awasthi and G A Ansari
      Drug Metabolism and Disposition March 1996, 24 (3) 371-374;

  6. Axelson, J E

    1. Hepatic first-pass uptake of diphenhydramine. A comparative study between fetal and adult sheep.
      G R Tonn, E Kwan, C Hall, K W Riggs, J E Axelson and D W Rurak
      Drug Metabolism and Disposition March 1996, 24 (3) 273-281;

B

  1. Bajpai, K K

    1. Interactions of melphalan with glutathione and the role of glutathione S-transferase.
      S Awasthi, K K Bajpai, J T Piper, S S Singhal, A Ballatore, W E Seifert, Y C Awasthi and G A Ansari
      Drug Metabolism and Disposition March 1996, 24 (3) 371-374;

  2. Balani, S K

    1. Role of cytochrome P450 3A4 in human metabolism of MK-639, a potent human immunodeficiency virus protease inhibitor.
      M Chiba, M Hensleigh, J A Nishime, S K Balani and J H Lin
      Drug Metabolism and Disposition March 1996, 24 (3) 307-314;

  3. Ballatore, A

    1. Interactions of melphalan with glutathione and the role of glutathione S-transferase.
      S Awasthi, K K Bajpai, J T Piper, S S Singhal, A Ballatore, W E Seifert, Y C Awasthi and G A Ansari
      Drug Metabolism and Disposition March 1996, 24 (3) 371-374;

  4. Bennani, Y L

    1. Oxidative and reductive metabolism of 9-cis-retinoic acid in the rat. Identification of 13,14-dihydro-9-cis-retinoic acid and its taurine conjugate.
      M A Shirley, Y L Bennani, M F Boehm, A P Breau, C Pathirana and E H Ulm
      Drug Metabolism and Disposition March 1996, 24 (3) 293-302;

  5. Bergeron, R J

    1. Metabolism and pharmacokinetics of N1,N14-diethylhomospermine.
      R J Bergeron, W R Weimar, G Luchetta, C A Sninsky and J Wiegand
      Drug Metabolism and Disposition March 1996, 24 (3) 334-343;

  6. Boehm, M F

    1. Oxidative and reductive metabolism of 9-cis-retinoic acid in the rat. Identification of 13,14-dihydro-9-cis-retinoic acid and its taurine conjugate.
      M A Shirley, Y L Bennani, M F Boehm, A P Breau, C Pathirana and E H Ulm
      Drug Metabolism and Disposition March 1996, 24 (3) 293-302;

  7. Bradshaw, T P

    1. CYP3A-like cytochrome P450-mediated metabolism and polarized efflux of cyclosporin A in Caco-2 cells.
      L S Gan, M A Moseley, B Khosla, P F Augustijns, T P Bradshaw, R W Hendren and D R Thakker
      Drug Metabolism and Disposition March 1996, 24 (3) 344-349;

  8. Breau, A P

    1. Oxidative and reductive metabolism of 9-cis-retinoic acid in the rat. Identification of 13,14-dihydro-9-cis-retinoic acid and its taurine conjugate.
      M A Shirley, Y L Bennani, M F Boehm, A P Breau, C Pathirana and E H Ulm
      Drug Metabolism and Disposition March 1996, 24 (3) 293-302;

  9. Brouwer, K L

    1. Influence of age and gender on valproic acid glucuronidation in rats.
      C Chen, P W Slattum, K L Brouwer and G M Pollack
      Drug Metabolism and Disposition March 1996, 24 (3) 367-370;

  10. Burlew, B S

    1. Metoprolol metabolism via cytochrome P4502D6 in ethnic populations.
      J A Johnson and B S Burlew
      Drug Metabolism and Disposition March 1996, 24 (3) 350-355;

C

  1. Chen, C

    1. Influence of age and gender on valproic acid glucuronidation in rats.
      C Chen, P W Slattum, K L Brouwer and G M Pollack
      Drug Metabolism and Disposition March 1996, 24 (3) 367-370;

  2. Chiba, M

    1. Role of cytochrome P450 3A4 in human metabolism of MK-639, a potent human immunodeficiency virus protease inhibitor.
      M Chiba, M Hensleigh, J A Nishime, S K Balani and J H Lin
      Drug Metabolism and Disposition March 1996, 24 (3) 307-314;

  3. Christ, D D

    1. Effects of the novel immunosuppressant brequinar on hepatic UDP-glucuronic acid levels and UDP-glucuronyltransferase activities in the rat.
      S Diamond and D D Christ
      Drug Metabolism and Disposition March 1996, 24 (3) 375-376;

  4. Coffman, B L

    1. Purification and properties of two rat liver phenobarbital-inducible UDP-glucuronosyltransferases that catalyze the glucuronidation of opioids.
      B L Coffman, G R Rios and T R Tephly
      Drug Metabolism and Disposition March 1996, 24 (3) 329-333;

  5. Colon, F

    1. Dose-related distribution of codeine and its metabolites into rat hair.
      S P Gygi, F Colon, R B Raftogianis, R E Galinsky, D G Wilkins and D E Rollins
      Drug Metabolism and Disposition March 1996, 24 (3) 282-287;

  6. Cundy, K C

    1. Effect of probenecid on the distribution, metabolism, and excretion of cidofovir in rabbits.
      K C Cundy, Z H Li and W A Lee
      Drug Metabolism and Disposition March 1996, 24 (3) 315-321;

D

  1. Diamond, S

    1. Effects of the novel immunosuppressant brequinar on hepatic UDP-glucuronic acid levels and UDP-glucuronyltransferase activities in the rat.
      S Diamond and D D Christ
      Drug Metabolism and Disposition March 1996, 24 (3) 375-376;

  2. Doerge, L

    1. Influence of the degree of renal dysfunction on the pharmacokinetic properties of the novel recombinant plasminogen activator reteplase in rats.
      U Martin, L Doerge, K Stegmeier and B Müller-Beckmann
      Drug Metabolism and Disposition March 1996, 24 (3) 288-292;

  3. Dunbar, D

    1. Characterization of rat small intestinal cytochrome P450 composition and inducibility.
      Q Y Zhang, J Wikoff, D Dunbar and L Kaminsky
      Drug Metabolism and Disposition March 1996, 24 (3) 322-328;

E

  1. Ekins, S

    1. Short-term maintenance of phase I and II metabolism in precision-cut liver slices in dynamic organ culture.
      S Ekins
      Drug Metabolism and Disposition March 1996, 24 (3) 364-366;

G

  1. Galinsky, R E

    1. Dose-related distribution of codeine and its metabolites into rat hair.
      S P Gygi, F Colon, R B Raftogianis, R E Galinsky, D G Wilkins and D E Rollins
      Drug Metabolism and Disposition March 1996, 24 (3) 282-287;

  2. Gan, L S

    1. CYP3A-like cytochrome P450-mediated metabolism and polarized efflux of cyclosporin A in Caco-2 cells.
      L S Gan, M A Moseley, B Khosla, P F Augustijns, T P Bradshaw, R W Hendren and D R Thakker
      Drug Metabolism and Disposition March 1996, 24 (3) 344-349;

  3. Green, M D

    1. Glucuronidation of amines and hydroxylated xenobiotics and endobiotics catalyzed by expressed human UGT1.4 protein.
      M D Green and T R Tephly
      Drug Metabolism and Disposition March 1996, 24 (3) 356-363;

  4. Gygi, S P

    1. Dose-related distribution of codeine and its metabolites into rat hair.
      S P Gygi, F Colon, R B Raftogianis, R E Galinsky, D G Wilkins and D E Rollins
      Drug Metabolism and Disposition March 1996, 24 (3) 282-287;

H

  1. Hall, C

    1. Hepatic first-pass uptake of diphenhydramine. A comparative study between fetal and adult sheep.
      G R Tonn, E Kwan, C Hall, K W Riggs, J E Axelson and D W Rurak
      Drug Metabolism and Disposition March 1996, 24 (3) 273-281;

  2. Hendren, R W

    1. CYP3A-like cytochrome P450-mediated metabolism and polarized efflux of cyclosporin A in Caco-2 cells.
      L S Gan, M A Moseley, B Khosla, P F Augustijns, T P Bradshaw, R W Hendren and D R Thakker
      Drug Metabolism and Disposition March 1996, 24 (3) 344-349;

  3. Hensleigh, M

    1. Role of cytochrome P450 3A4 in human metabolism of MK-639, a potent human immunodeficiency virus protease inhibitor.
      M Chiba, M Hensleigh, J A Nishime, S K Balani and J H Lin
      Drug Metabolism and Disposition March 1996, 24 (3) 307-314;

J

  1. Johnson, J A

    1. Metoprolol metabolism via cytochrome P4502D6 in ethnic populations.
      J A Johnson and B S Burlew
      Drug Metabolism and Disposition March 1996, 24 (3) 350-355;

K

  1. Kalow, W

    1. A sensitive method for determination of cytochrome P4502D6 activity in vitro using bupranolol as substrate.
      G Appanna, B K Tang, R Mller and W Kalow
      Drug Metabolism and Disposition March 1996, 24 (3) 303-306;

  2. Kaminsky, L

    1. Characterization of rat small intestinal cytochrome P450 composition and inducibility.
      Q Y Zhang, J Wikoff, D Dunbar and L Kaminsky
      Drug Metabolism and Disposition March 1996, 24 (3) 322-328;

  3. Khosla, B

    1. CYP3A-like cytochrome P450-mediated metabolism and polarized efflux of cyclosporin A in Caco-2 cells.
      L S Gan, M A Moseley, B Khosla, P F Augustijns, T P Bradshaw, R W Hendren and D R Thakker
      Drug Metabolism and Disposition March 1996, 24 (3) 344-349;

  4. Kwan, E

    1. Hepatic first-pass uptake of diphenhydramine. A comparative study between fetal and adult sheep.
      G R Tonn, E Kwan, C Hall, K W Riggs, J E Axelson and D W Rurak
      Drug Metabolism and Disposition March 1996, 24 (3) 273-281;

L

  1. Lee, W A

    1. Effect of probenecid on the distribution, metabolism, and excretion of cidofovir in rabbits.
      K C Cundy, Z H Li and W A Lee
      Drug Metabolism and Disposition March 1996, 24 (3) 315-321;

  2. Li, Z H

    1. Effect of probenecid on the distribution, metabolism, and excretion of cidofovir in rabbits.
      K C Cundy, Z H Li and W A Lee
      Drug Metabolism and Disposition March 1996, 24 (3) 315-321;

  3. Lin, J H

    1. Role of cytochrome P450 3A4 in human metabolism of MK-639, a potent human immunodeficiency virus protease inhibitor.
      M Chiba, M Hensleigh, J A Nishime, S K Balani and J H Lin
      Drug Metabolism and Disposition March 1996, 24 (3) 307-314;

  4. Luchetta, G

    1. Metabolism and pharmacokinetics of N1,N14-diethylhomospermine.
      R J Bergeron, W R Weimar, G Luchetta, C A Sninsky and J Wiegand
      Drug Metabolism and Disposition March 1996, 24 (3) 334-343;

M

  1. Martin, U

    1. Influence of the degree of renal dysfunction on the pharmacokinetic properties of the novel recombinant plasminogen activator reteplase in rats.
      U Martin, L Doerge, K Stegmeier and B Müller-Beckmann
      Drug Metabolism and Disposition March 1996, 24 (3) 288-292;

  2. Mller, R

    1. A sensitive method for determination of cytochrome P4502D6 activity in vitro using bupranolol as substrate.
      G Appanna, B K Tang, R Mller and W Kalow
      Drug Metabolism and Disposition March 1996, 24 (3) 303-306;

  3. Moseley, M A

    1. CYP3A-like cytochrome P450-mediated metabolism and polarized efflux of cyclosporin A in Caco-2 cells.
      L S Gan, M A Moseley, B Khosla, P F Augustijns, T P Bradshaw, R W Hendren and D R Thakker
      Drug Metabolism and Disposition March 1996, 24 (3) 344-349;

  4. Müller-Beckmann, B

    1. Influence of the degree of renal dysfunction on the pharmacokinetic properties of the novel recombinant plasminogen activator reteplase in rats.
      U Martin, L Doerge, K Stegmeier and B Müller-Beckmann
      Drug Metabolism and Disposition March 1996, 24 (3) 288-292;

N

  1. Nishime, J A

    1. Role of cytochrome P450 3A4 in human metabolism of MK-639, a potent human immunodeficiency virus protease inhibitor.
      M Chiba, M Hensleigh, J A Nishime, S K Balani and J H Lin
      Drug Metabolism and Disposition March 1996, 24 (3) 307-314;

P

  1. Pathirana, C

    1. Oxidative and reductive metabolism of 9-cis-retinoic acid in the rat. Identification of 13,14-dihydro-9-cis-retinoic acid and its taurine conjugate.
      M A Shirley, Y L Bennani, M F Boehm, A P Breau, C Pathirana and E H Ulm
      Drug Metabolism and Disposition March 1996, 24 (3) 293-302;

  2. Piper, J T

    1. Interactions of melphalan with glutathione and the role of glutathione S-transferase.
      S Awasthi, K K Bajpai, J T Piper, S S Singhal, A Ballatore, W E Seifert, Y C Awasthi and G A Ansari
      Drug Metabolism and Disposition March 1996, 24 (3) 371-374;

  3. Pollack, G M

    1. Influence of age and gender on valproic acid glucuronidation in rats.
      C Chen, P W Slattum, K L Brouwer and G M Pollack
      Drug Metabolism and Disposition March 1996, 24 (3) 367-370;

R

  1. Raftogianis, R B

    1. Dose-related distribution of codeine and its metabolites into rat hair.
      S P Gygi, F Colon, R B Raftogianis, R E Galinsky, D G Wilkins and D E Rollins
      Drug Metabolism and Disposition March 1996, 24 (3) 282-287;

  2. Riggs, K W

    1. Hepatic first-pass uptake of diphenhydramine. A comparative study between fetal and adult sheep.
      G R Tonn, E Kwan, C Hall, K W Riggs, J E Axelson and D W Rurak
      Drug Metabolism and Disposition March 1996, 24 (3) 273-281;

  3. Rios, G R

    1. Purification and properties of two rat liver phenobarbital-inducible UDP-glucuronosyltransferases that catalyze the glucuronidation of opioids.
      B L Coffman, G R Rios and T R Tephly
      Drug Metabolism and Disposition March 1996, 24 (3) 329-333;

  4. Rollins, D E

    1. Dose-related distribution of codeine and its metabolites into rat hair.
      S P Gygi, F Colon, R B Raftogianis, R E Galinsky, D G Wilkins and D E Rollins
      Drug Metabolism and Disposition March 1996, 24 (3) 282-287;

  5. Rurak, D W

    1. Hepatic first-pass uptake of diphenhydramine. A comparative study between fetal and adult sheep.
      G R Tonn, E Kwan, C Hall, K W Riggs, J E Axelson and D W Rurak
      Drug Metabolism and Disposition March 1996, 24 (3) 273-281;

S

  1. Seifert, W E

    1. Interactions of melphalan with glutathione and the role of glutathione S-transferase.
      S Awasthi, K K Bajpai, J T Piper, S S Singhal, A Ballatore, W E Seifert, Y C Awasthi and G A Ansari
      Drug Metabolism and Disposition March 1996, 24 (3) 371-374;

  2. Shirley, M A

    1. Oxidative and reductive metabolism of 9-cis-retinoic acid in the rat. Identification of 13,14-dihydro-9-cis-retinoic acid and its taurine conjugate.
      M A Shirley, Y L Bennani, M F Boehm, A P Breau, C Pathirana and E H Ulm
      Drug Metabolism and Disposition March 1996, 24 (3) 293-302;

  3. Singhal, S S

    1. Interactions of melphalan with glutathione and the role of glutathione S-transferase.
      S Awasthi, K K Bajpai, J T Piper, S S Singhal, A Ballatore, W E Seifert, Y C Awasthi and G A Ansari
      Drug Metabolism and Disposition March 1996, 24 (3) 371-374;

  4. Slattum, P W

    1. Influence of age and gender on valproic acid glucuronidation in rats.
      C Chen, P W Slattum, K L Brouwer and G M Pollack
      Drug Metabolism and Disposition March 1996, 24 (3) 367-370;

  5. Sninsky, C A

    1. Metabolism and pharmacokinetics of N1,N14-diethylhomospermine.
      R J Bergeron, W R Weimar, G Luchetta, C A Sninsky and J Wiegand
      Drug Metabolism and Disposition March 1996, 24 (3) 334-343;

  6. Stegmeier, K

    1. Influence of the degree of renal dysfunction on the pharmacokinetic properties of the novel recombinant plasminogen activator reteplase in rats.
      U Martin, L Doerge, K Stegmeier and B Müller-Beckmann
      Drug Metabolism and Disposition March 1996, 24 (3) 288-292;

T

  1. Tang, B K

    1. A sensitive method for determination of cytochrome P4502D6 activity in vitro using bupranolol as substrate.
      G Appanna, B K Tang, R Mller and W Kalow
      Drug Metabolism and Disposition March 1996, 24 (3) 303-306;

  2. Tephly, T R

    1. Purification and properties of two rat liver phenobarbital-inducible UDP-glucuronosyltransferases that catalyze the glucuronidation of opioids.
      B L Coffman, G R Rios and T R Tephly
      Drug Metabolism and Disposition March 1996, 24 (3) 329-333;
    2. Glucuronidation of amines and hydroxylated xenobiotics and endobiotics catalyzed by expressed human UGT1.4 protein.
      M D Green and T R Tephly
      Drug Metabolism and Disposition March 1996, 24 (3) 356-363;

  3. Thakker, D R

    1. CYP3A-like cytochrome P450-mediated metabolism and polarized efflux of cyclosporin A in Caco-2 cells.
      L S Gan, M A Moseley, B Khosla, P F Augustijns, T P Bradshaw, R W Hendren and D R Thakker
      Drug Metabolism and Disposition March 1996, 24 (3) 344-349;

  4. Tonn, G R

    1. Hepatic first-pass uptake of diphenhydramine. A comparative study between fetal and adult sheep.
      G R Tonn, E Kwan, C Hall, K W Riggs, J E Axelson and D W Rurak
      Drug Metabolism and Disposition March 1996, 24 (3) 273-281;

U

  1. Ulm, E H

    1. Oxidative and reductive metabolism of 9-cis-retinoic acid in the rat. Identification of 13,14-dihydro-9-cis-retinoic acid and its taurine conjugate.
      M A Shirley, Y L Bennani, M F Boehm, A P Breau, C Pathirana and E H Ulm
      Drug Metabolism and Disposition March 1996, 24 (3) 293-302;

W

  1. Weimar, W R

    1. Metabolism and pharmacokinetics of N1,N14-diethylhomospermine.
      R J Bergeron, W R Weimar, G Luchetta, C A Sninsky and J Wiegand
      Drug Metabolism and Disposition March 1996, 24 (3) 334-343;

  2. Wiegand, J

    1. Metabolism and pharmacokinetics of N1,N14-diethylhomospermine.
      R J Bergeron, W R Weimar, G Luchetta, C A Sninsky and J Wiegand
      Drug Metabolism and Disposition March 1996, 24 (3) 334-343;

  3. Wikoff, J

    1. Characterization of rat small intestinal cytochrome P450 composition and inducibility.
      Q Y Zhang, J Wikoff, D Dunbar and L Kaminsky
      Drug Metabolism and Disposition March 1996, 24 (3) 322-328;

  4. Wilkins, D G

    1. Dose-related distribution of codeine and its metabolites into rat hair.
      S P Gygi, F Colon, R B Raftogianis, R E Galinsky, D G Wilkins and D E Rollins
      Drug Metabolism and Disposition March 1996, 24 (3) 282-287;

Z

  1. Zhang, Q Y

    1. Characterization of rat small intestinal cytochrome P450 composition and inducibility.
      Q Y Zhang, J Wikoff, D Dunbar and L Kaminsky
      Drug Metabolism and Disposition March 1996, 24 (3) 322-328;
Back to top

In this issue

Advertisement